Skip to content
Institutional Investor seed Series A early-stage Est. 2014

4Bio Capital

Venture capital investment firm

📍 London, United Kingdom

About This Fund

Venture capital investment firm. It is focused solely on the advanced therapies sector. It invest in, support, and grow early stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. It looks for viable, high-quality opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome.

Investment Focus

Sectors
advanced therapies cell and gene therapy RNA-based therapy targeted therapies microbiome radiopharmaceuticals
Stages
seed Series A early-stage
Check Size $5M-$30M
Geography
USA UK Europe

What They Look For

early-stage companies developing potentially curative treatments in areas of high unmet medical need; primarily UK, Europe, US; high-quality opportunities addressing technical gaps in biotech

Preparing to pitch 4Bio Capital?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →